The Food and Drug Administration said today that following yesterday's positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, it would rapidly work toward finalization and issuance of an emergency use authorization for the COVID-19 vaccine.
The FDA gave no specific timeline.
The agency has also notified the U.S. Centers for Disease Control and Prevention and Operation Warp Speed so that they can execute their plans for timely vaccine distribution.
Learn on-demand, earn credit, find products and solutions. Get Started >>
Approval means vaccine distribution would be on Operation Warp Speed's schedule for distribution to frontline healthcare workers and vulnerable populations in long-term care facilities by mid-month.
The FDA advisory committee has scheduled another meeting to review the Moderna vaccine on Thursday, December 17.
See our continuing vaccine coverage here:
Email the writer: firstname.lastname@example.org